When we reach into a medicine cabinet we aim to find something to relieve our symptoms and treat our ailments. This could be a painkiller for a headache, an antibiotic for an infection, or insulin for diabetes. Typically, we assume that what’s inside that blister pack, bottle or vial is real, safe, and effective. But what if it’s not, and not only may it be ineffective at relieving our symptoms, but it could even cause harm? That unsettling question is at the heart of a groundbreaking new study from the University of Plymouth. Led by Dr Maysa Falah and Dr Michael Dillon, the research team explored an underreported problem that quietly afflicts health systems worldwide: substandard and falsified medicines, or SF medicines for short. Through their research in Jordan, they offer a glimpse into how widespread and misunderstood the issue truly is, not just among the public, but also in pharmacies and clinics, revealing both the prevalence of poor-quality medicines and the deep uncertainty around what we trust to put in our bodies.

When a baby is born, the bones of the skull are meant to behave like the slats of a wooden barrel, flexible enough to slide into the correct orientation as the brain beneath them doubles in size during the first year of life. However, in about seven of every 100,000 births one of those seams between the bones of the skull (called a suture) closes too early along a single side of the forehead, a condition called unicoronal synostosis (or UCS). Instead of rounding out evenly, the skull twists: one brow pulls backward, the opposite brow juts forward, the eye sockets tilt, and the nose shifts off‑centre. Beyond cosmetic considerations such as the visible asymmetry, these children can also face raised brain pressure, vision problems and slower development.